Jochen Huehn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jochen Huehn has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Alf Hamann
Experimental Rheumatology, Charité Universitaetsmedizin Berlin, Campus Mitte, 10117 Berlin, Germany
11 shared publications- Kerstin Siegmund
Institute for Cell Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria
6 shared publications Christiane Siewert
Experimentelle Rheumatologie, Charité Universitaetsmedizin Berlin, Campus Mitte, Berlin, Germany
5 shared publications- Alexander Scheffold
Institute of Immunology, Christian-Albrechts-University of Kiel and University Hospital Schleswig-Holstein (UKSH), Kiel, Germany
4 shared publications - Julia K. Polansky
BIH Center for Regenerative Therapies, Immuno-Epigenetics, BIH at Charité – Universitätsmedizin Berlin, Berlin, Germany
4 shared publications Stefan Floess
Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany
4 shared publications
Latest Publications
- 3 April 2009
- Published by Wiley
- p. 21-38
Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells
- 3 April 2009
- Published by Wiley
- p. 21-38
Epigenetic Regulation of Foxp3 Expression in Regulatory T Cells
- Top Cited PapersOpen Access
- 20 May 2008
- Published by Wiley in European Journal of Immunology
- Vol. 38 (6) , 1654-1663
DNA methylation controls Foxp3 gene expression
Compelling evidence suggests that Foxp3‐expressing CD25+CD4+ regulatory T cells (Treg) are generated within the thymus as a separate lineage. However, Foxp3+CD4+ Treg can also be generated de novo in a TGF‐β‐dependent process from naive T cells by TCR triggering. Recently, we have shown that naturally occurring, but not in vitro TGF‐β‐induced Foxp3+ Treg display stable Foxp3 expression that was associated with selective demethylation of an evolutionarily conserved element within the Foxp3 locus named TSDR (Treg‐specific demethylated region). Here, we report that inhibition of DNA methylation by azacytidine, even in absence of exogenous TGF‐β, not only promoted de novo induction of Foxp3 expression during priming, but also conferred stability of Foxp3 expression upon restimulation. Most notably, such stable Foxp3 expression was found only for cells displaying enhanced TSDR demethylation. In contrast, in vitro TSDR methylation diminished its transcriptional activity. Foxp3+ Treg generated in vivo by DEC‐205‐mediated targeting of agonist ligands to dendritic cells showed long‐term survival in the absence of the inducing antigen and exhibited efficient TSDR demethylation. Together, our data suggest that TSDR is an important methylation‐sensitive element regulating Foxp3 expression and demonstrate that epigenetic imprinting in this region is critical for establishment of a stable Treg lineage.Supporting Information for this article is available at www.wiley‐vch.de/contents/jc_2040/2008/38105_s.pdf
- 20 May 2008
- Published by Wiley in European Journal of Immunology
- Vol. 38 (6) , 1654-1663
Top Cited PapersOpen AccessDNA methylation controls Foxp3 gene expression
Compelling evidence suggests that Foxp3‐expressing CD25+CD4+ regulatory T cells (Treg) are generated within the thymus as a separate lineage. However, Foxp3+CD4+ Treg can also be generated de novo in a TGF‐β‐dependent process from naive T cells by TCR triggering. Recently, we have shown that naturally occurring, but not in vitro TGF‐β‐induced Foxp3+ Treg display stable Foxp3 expression that was associated with selective demethylation of an evolutionarily conserved element within the Foxp3 locus named TSDR (Treg‐specific demethylated region). Here, we report that inhibition of DNA methylation by azacytidine, even in absence of exogenous TGF‐β, not only promoted de novo induction of Foxp3 expression during priming, but also conferred stability of Foxp3 expression upon restimulation. Most notably, such stable Foxp3 expression was found only for cells displaying enhanced TSDR demethylation. In contrast, in vitro TSDR methylation diminished its transcriptional activity. Foxp3+ Treg generated in vivo by DEC‐205‐mediated targeting of agonist ligands to dendritic cells showed long‐term survival in the absence of the inducing antigen and exhibited efficient TSDR demethylation. Together, our data suggest that TSDR is an important methylation‐sensitive element regulating Foxp3 expression and demonstrate that epigenetic imprinting in this region is critical for establishment of a stable Treg lineage.Supporting Information for this article is available at www.wiley‐vch.de/contents/jc_2040/2008/38105_s.pdf
- Open Access
- 1 January 2008
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 180 (1) , 146-155
Experience-Driven Development: Effector/Memory-Like αE+Foxp3+ Regulatory T Cells Originate from Both Naive T Cells and Naturally Occurring Naive-Like Regulatory T Cells
Naturally occurring Foxp3+CD25+CD4+ regulatory T cells (Treg) have initially been described as anergic cells; however, more recent in vivo studies suggest that Tregs vigorously proliferate under both homeostatic as well as inflammatory conditions. We have previously identified a subset of murine CD4+ Tregs, which is characterized by expression of the integrin αEβ7 and which displays an effector/memory-like phenotype indicative of Ag-specific expansion and differentiation. In the present study, the αE+ Treg subset was found to contain a large fraction of cycling cells under homeostatic conditions in healthy mice. Using an adoptive transfer system of Ag-specific T cells, we could demonstrate that the vast majority of transferred natural, naive-like CD25+CD4+ Tregs acquired expression of the integrin αEβ7 upon tolerogenic application of Ag via the oral route. In addition, using the same system, Foxp3+ Tregs could be de novo induced from conventional naive CD25−CD4+ T cells, and this conversion was associated with concomitant expression of αE. These findings suggest that Tregs expressing the integrin αE are effector/memory Tregs with a high turnover rate that can develop in the periphery upon Ag contact under tolerogenic conditions, both from thymic-derived CD25+CD4+ Tregs with a naive-like phenotype as well as from conventional naive T cells.
- 1 January 2008
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 180 (1) , 146-155
Open AccessExperience-Driven Development: Effector/Memory-Like αE+Foxp3+ Regulatory T Cells Originate from Both Naive T Cells and Naturally Occurring Naive-Like Regulatory T Cells
Naturally occurring Foxp3+CD25+CD4+ regulatory T cells (Treg) have initially been described as anergic cells; however, more recent in vivo studies suggest that Tregs vigorously proliferate under both homeostatic as well as inflammatory conditions. We have previously identified a subset of murine CD4+ Tregs, which is characterized by expression of the integrin αEβ7 and which displays an effector/memory-like phenotype indicative of Ag-specific expansion and differentiation. In the present study, the αE+ Treg subset was found to contain a large fraction of cycling cells under homeostatic conditions in healthy mice. Using an adoptive transfer system of Ag-specific T cells, we could demonstrate that the vast majority of transferred natural, naive-like CD25+CD4+ Tregs acquired expression of the integrin αEβ7 upon tolerogenic application of Ag via the oral route. In addition, using the same system, Foxp3+ Tregs could be de novo induced from conventional naive CD25−CD4+ T cells, and this conversion was associated with concomitant expression of αE. These findings suggest that Tregs expressing the integrin αE are effector/memory Tregs with a high turnover rate that can develop in the periphery upon Ag contact under tolerogenic conditions, both from thymic-derived CD25+CD4+ Tregs with a naive-like phenotype as well as from conventional naive T cells.
- 25 August 2007
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 66 (5) , 417-420
To be or not to be a Treg
Regulatorische T-Zellen (Tregs) bergen aufgrund ihrer potenten immunsuppressorischen Eigenschaften ein großes therapeutisches Potenzial für die Behandlung von Autoimmunerkrankungen. Der Großteil dieser Zellen exprimiert den Transkriptionsfaktor Foxp3, der für die Entwicklung und Funktion der Tregs essenziell ist. Hier diskutieren wir die Ergebnisse einer kürzlich veröffentlichten Arbeit, in der wir zeigen konnten, dass die permanente Foxp3-Expression in stabilen Tregs durch epigenetische Mechanismen kontrolliert ist – eine Beobachtung, welche eine signifikante Bedeutung für den therapeutischen Einsatz von Tregs in der Klinik hat.
- 25 August 2007
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 66 (5) , 417-420
To be or not to be a Treg
Regulatorische T-Zellen (Tregs) bergen aufgrund ihrer potenten immunsuppressorischen Eigenschaften ein großes therapeutisches Potenzial für die Behandlung von Autoimmunerkrankungen. Der Großteil dieser Zellen exprimiert den Transkriptionsfaktor Foxp3, der für die Entwicklung und Funktion der Tregs essenziell ist. Hier diskutieren wir die Ergebnisse einer kürzlich veröffentlichten Arbeit, in der wir zeigen konnten, dass die permanente Foxp3-Expression in stabilen Tregs durch epigenetische Mechanismen kontrolliert ist – eine Beobachtung, welche eine signifikante Bedeutung für den therapeutischen Einsatz von Tregs in der Klinik hat.
- Open Access
- 24 May 2007
- Published by Wiley in European Journal of Immunology
- Vol. 37 (6) , 1575-1583
Distinctive role of CCR7 in migration and functional activity of naive‐ and effector/memory‐like Treg subsets
Foxp3+CD25+CD4+ Treg play a fundamental role in the maintenance of self tolerance and the control of inflammatory reactions. Previous data demonstrated a division of labor between naive‐ and effector/memory‐like Treg subsets, which is largely based on their lymph node‐recirculating and inflammation‐seeking migration behavior, respectively. The chemokine receptor CCR7 is expressed on both types of Treg subsets, albeit at different levels. Whether it fulfills similar or distinct roles in these subsets has not been studied so far. We here show that the recirculation of naive‐like Treg through LN and, to some extent, the gut is dependent on CCR7. Lack of CCR7 not only prevents recirculation, but also almost completely abolishes the ability of naive‐like Treg to control the priming phase of an immune response. In contrast, CCR7 deficiency in effector/memory‐like Treg promotes their accumulation in inflamed sites, compatible with a role of CCR7 for exit from the tissue. Local Treg accumulation was accompanied by an enhanced suppression of inflammation. Together, our findings provide conclusive evidence that CCR7 expression on Treg differentially controls in vivo function of the naive‐ and effector/memory‐like subsets.
- 24 May 2007
- Published by Wiley in European Journal of Immunology
- Vol. 37 (6) , 1575-1583
Open AccessDistinctive role of CCR7 in migration and functional activity of naive‐ and effector/memory‐like Treg subsets
Foxp3+CD25+CD4+ Treg play a fundamental role in the maintenance of self tolerance and the control of inflammatory reactions. Previous data demonstrated a division of labor between naive‐ and effector/memory‐like Treg subsets, which is largely based on their lymph node‐recirculating and inflammation‐seeking migration behavior, respectively. The chemokine receptor CCR7 is expressed on both types of Treg subsets, albeit at different levels. Whether it fulfills similar or distinct roles in these subsets has not been studied so far. We here show that the recirculation of naive‐like Treg through LN and, to some extent, the gut is dependent on CCR7. Lack of CCR7 not only prevents recirculation, but also almost completely abolishes the ability of naive‐like Treg to control the priming phase of an immune response. In contrast, CCR7 deficiency in effector/memory‐like Treg promotes their accumulation in inflamed sites, compatible with a role of CCR7 for exit from the tissue. Local Treg accumulation was accompanied by an enhanced suppression of inflammation. Together, our findings provide conclusive evidence that CCR7 expression on Treg differentially controls in vivo function of the naive‐ and effector/memory‐like subsets.
- Open Access
- 28 March 2007
- Published by Wiley in European Journal of Immunology
- Vol. 37 (4) , 978-989
Induction of organ‐selective CD4+ regulatory T cell homing
Compelling evidence suggests that Foxp3+CD25+CD4+ Treg play a fundamental role in immunoregulation. We have previously demonstrated that Treg have to enter peripheral tissues to suppress ongoing inflammation. However, relatively little is known about how Treg acquire the expression of homing receptors required for tissue‐ or inflammation‐specific migration. Migratory properties of conventional naïve T cells are shaped by the tissue microenvironment and organ‐specific dendritic cells during priming. Here, we show that this basic concept also holds true for CD25+CD4+ Treg: Priming of Treg within peripheral LN led to the expression of selectin ligands, which facilitate migration into inflamed skin, whereas activation within mesenteric LN led to induction of the integrin α4β7, which is required for migration into mucosal tissues. Furthermore, we could establish in vitro culture systems containing either dendritic cells from mesenteric and peripheral LN, or retinoic acid and IL‐12 as polarizing compounds to induce mucosa‐ and skin‐seeking Treg, respectively. Together, our results demonstrate that Treg, similarly to conventional T cells, can be configured with organ‐selective homing properties allowing efficient targeting into distinct tissues.
- 28 March 2007
- Published by Wiley in European Journal of Immunology
- Vol. 37 (4) , 978-989
Open AccessInduction of organ‐selective CD4+ regulatory T cell homing
Compelling evidence suggests that Foxp3+CD25+CD4+ Treg play a fundamental role in immunoregulation. We have previously demonstrated that Treg have to enter peripheral tissues to suppress ongoing inflammation. However, relatively little is known about how Treg acquire the expression of homing receptors required for tissue‐ or inflammation‐specific migration. Migratory properties of conventional naïve T cells are shaped by the tissue microenvironment and organ‐specific dendritic cells during priming. Here, we show that this basic concept also holds true for CD25+CD4+ Treg: Priming of Treg within peripheral LN led to the expression of selectin ligands, which facilitate migration into inflamed skin, whereas activation within mesenteric LN led to induction of the integrin α4β7, which is required for migration into mucosal tissues. Furthermore, we could establish in vitro culture systems containing either dendritic cells from mesenteric and peripheral LN, or retinoic acid and IL‐12 as polarizing compounds to induce mucosa‐ and skin‐seeking Treg, respectively. Together, our results demonstrate that Treg, similarly to conventional T cells, can be configured with organ‐selective homing properties allowing efficient targeting into distinct tissues.
- Top Cited PapersOpen Access
- 30 January 2007
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 5 (2) , e38
Epigenetic Control of the foxp3 Locus in Regulatory T Cells
Compelling evidence suggests that the transcription factor Foxp3 acts as a master switch governing the development and function of CD4+ regulatory T cells (Tregs). However, whether transcriptional control of Foxp3 expression itself contributes to the development of a stable Treg lineage has thus far not been investigated. We here identified an evolutionarily conserved region within the foxp3 locus upstream of exon-1 possessing transcriptional activity. Bisulphite sequencing and chromatin immunoprecipitation revealed complete demethylation of CpG motifs as well as histone modifications within the conserved region in ex vivo isolated Foxp3+CD25+CD4+ Tregs, but not in naïve CD25−CD4+ T cells. Partial DNA demethylation is already found within developing Foxp3+ thymocytes; however, Tregs induced by TGF-β in vitro display only incomplete demethylation despite high Foxp3 expression. In contrast to natural Tregs, these TGF-β–induced Foxp3+ Tregs lose both Foxp3 expression and suppressive activity upon restimulation in the absence of TGF-β. Our data suggest that expression of Foxp3 must be stabilized by epigenetic modification to allow the development of a permanent suppressor cell lineage, a finding of significant importance for therapeutic applications involving induction or transfer of Tregs and for the understanding of long-term cell lineage decisions. Regulatory T cells play a pivotal role in the maintenance of self-tolerance within the immune system by preventing autoimmunity or excessive activation of the T cells that respond to pathogens (naïve and effector T cells). They differentiate within the thymus, but can also be de novo induced in the rest of the body. Mechanisms determining development of a stable regulatory T cell lineage are unknown. Our study provides evidence for a critical role of epigenetic modifications in the locus coding for the forkhead transcription factor Foxp3, which acts as a master switch controlling regulatory T cell development and function: An evolutionarily conserved region within the non-coding part of the gene contains CpG motifs, which are completely demethylated in regulatory T cells, but methylated in naïve and effector T cells, whereas we observed an inverse occurrence of acetylated histones, another epigenetic chromatin modification. Regulatory T cells induced in vitro—which, in contrast to natural regulatory T cells, do not display a stable regulatory T cell phenotype—display only incomplete DNA demethylation despite high Foxp3 expression. Our data suggest that expression of Foxp3 must be stabilized by epigenetic modification to result in a permanent suppressor cell lineage, a finding of significant importance for therapeutic applications involving induction or transfer of regulatory T cells and for the understanding of long-term cell lineage decisions.
- 30 January 2007
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 5 (2) , e38
Top Cited PapersOpen AccessEpigenetic Control of the foxp3 Locus in Regulatory T Cells
Compelling evidence suggests that the transcription factor Foxp3 acts as a master switch governing the development and function of CD4+ regulatory T cells (Tregs). However, whether transcriptional control of Foxp3 expression itself contributes to the development of a stable Treg lineage has thus far not been investigated. We here identified an evolutionarily conserved region within the foxp3 locus upstream of exon-1 possessing transcriptional activity. Bisulphite sequencing and chromatin immunoprecipitation revealed complete demethylation of CpG motifs as well as histone modifications within the conserved region in ex vivo isolated Foxp3+CD25+CD4+ Tregs, but not in naïve CD25−CD4+ T cells. Partial DNA demethylation is already found within developing Foxp3+ thymocytes; however, Tregs induced by TGF-β in vitro display only incomplete demethylation despite high Foxp3 expression. In contrast to natural Tregs, these TGF-β–induced Foxp3+ Tregs lose both Foxp3 expression and suppressive activity upon restimulation in the absence of TGF-β. Our data suggest that expression of Foxp3 must be stabilized by epigenetic modification to allow the development of a permanent suppressor cell lineage, a finding of significant importance for therapeutic applications involving induction or transfer of Tregs and for the understanding of long-term cell lineage decisions. Regulatory T cells play a pivotal role in the maintenance of self-tolerance within the immune system by preventing autoimmunity or excessive activation of the T cells that respond to pathogens (naïve and effector T cells). They differentiate within the thymus, but can also be de novo induced in the rest of the body. Mechanisms determining development of a stable regulatory T cell lineage are unknown. Our study provides evidence for a critical role of epigenetic modifications in the locus coding for the forkhead transcription factor Foxp3, which acts as a master switch controlling regulatory T cell development and function: An evolutionarily conserved region within the non-coding part of the gene contains CpG motifs, which are completely demethylated in regulatory T cells, but methylated in naïve and effector T cells, whereas we observed an inverse occurrence of acetylated histones, another epigenetic chromatin modification. Regulatory T cells induced in vitro—which, in contrast to natural regulatory T cells, do not display a stable regulatory T cell phenotype—display only incomplete DNA demethylation despite high Foxp3 expression. Our data suggest that expression of Foxp3 must be stabilized by epigenetic modification to result in a permanent suppressor cell lineage, a finding of significant importance for therapeutic applications involving induction or transfer of regulatory T cells and for the understanding of long-term cell lineage decisions.
- Open Access
- 1 March 2006
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 176 (5) , 2857-2863
Self-Limitation of Th1-Mediated Inflammation by IFN-γ
IFN-γ is an effector cytokine of cell-mediated immunity that plays an essential role in both innate and adaptive phases of an immune response. Interestingly, in several Th1-dependent autoimmune models, lack of IFN-γ is associated with an acceleration of disease. To distinguish the influence of IFN-γ on the polarization of naive precursors from the influence on effector cells, we used an adoptive transfer model of differentiated Ag-specific Th1 cells. In this study, IFN-γ displayed a dual function in a Th1-dependent immune reaction. In the early phase, IFN-γ accelerated the inflammation, whereas in the late phase it mediated the process of self-limitation. We demonstrated that IFN-γ limits the number of Th1 effector cells after Ag challenge. Studies using IFN-γR−/− mice as recipients showed that IFN-γ acts indirectly via host cells to regulate the pool size of Th1 cells. NO was a downstream effector molecule. Transfer experiments of Th1 cells into IFN-γ−/− mice revealed that Th1 cells control both themselves and the corresponding inflammation by the release of IFN-γ. Thus, the proinflammatory cytokine IFN-γ can act as a negative feedback regulator to control Th1-mediated immune responses.
- 1 March 2006
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 176 (5) , 2857-2863
Open AccessSelf-Limitation of Th1-Mediated Inflammation by IFN-γ
IFN-γ is an effector cytokine of cell-mediated immunity that plays an essential role in both innate and adaptive phases of an immune response. Interestingly, in several Th1-dependent autoimmune models, lack of IFN-γ is associated with an acceleration of disease. To distinguish the influence of IFN-γ on the polarization of naive precursors from the influence on effector cells, we used an adoptive transfer model of differentiated Ag-specific Th1 cells. In this study, IFN-γ displayed a dual function in a Th1-dependent immune reaction. In the early phase, IFN-γ accelerated the inflammation, whereas in the late phase it mediated the process of self-limitation. We demonstrated that IFN-γ limits the number of Th1 effector cells after Ag challenge. Studies using IFN-γR−/− mice as recipients showed that IFN-γ acts indirectly via host cells to regulate the pool size of Th1 cells. NO was a downstream effector molecule. Transfer experiments of Th1 cells into IFN-γ−/− mice revealed that Th1 cells control both themselves and the corresponding inflammation by the release of IFN-γ. Thus, the proinflammatory cytokine IFN-γ can act as a negative feedback regulator to control Th1-mediated immune responses.
- 1 December 2005
- Published by Elsevier in Trends in Immunology
- Vol. 26 (12) , 632-636
Homing to suppress: address codes for Treg migration
- 1 December 2005
- Published by Elsevier in Trends in Immunology
- Vol. 26 (12) , 632-636
Homing to suppress: address codes for Treg migration
- 1 November 2005
- Published by American Society of Hematology in Blood
- Vol. 106 (9) , 3097-3104
Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo
Regulatory T cells (Tregs) play a fundamental role in the suppression of different immune responses; however, compartments at which they exert suppressive functions in vivo are unknown. Although many groups have described the presence of Tregs within inflammatory sites, it has not been shown that inflamed tissues are, indeed, the sites of active suppression of ongoing immune reactions. Here, by using αE+ effector/memory-like Tregs from fucosyltransferase VII-deficient animals, which lack E/P-selectin ligands and fail to migrate into inflamed sites, we analyzed the functional importance of appropriate Treg localization for in vivo suppressive capacity in an inflammation model. Lack of suppression by Tregs deficient in E/P-selectin ligands demonstrates that immigration into inflamed sites is a prerequisite for the resolution of inflammatory reactions in vivo because these selectin ligands merely regulate entry into inflamed tissues. In contrast, control of proliferation of naive CD4+ T cells during the induction phase of the immune response is more efficiently exerted by the naive-like αE–CD25+ Treg subset preferentially recirculating through lymph nodes when compared with its inflammation-seeking counterpart. Together, these findings provide the first conclusive evidence that appropriate localization is crucial for in vivo activity of Tregs and might have significant implications for anti-inflammatory therapies targeting recruitment mechanisms.
- 1 November 2005
- Published by American Society of Hematology in Blood
- Vol. 106 (9) , 3097-3104
Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo
Regulatory T cells (Tregs) play a fundamental role in the suppression of different immune responses; however, compartments at which they exert suppressive functions in vivo are unknown. Although many groups have described the presence of Tregs within inflammatory sites, it has not been shown that inflamed tissues are, indeed, the sites of active suppression of ongoing immune reactions. Here, by using αE+ effector/memory-like Tregs from fucosyltransferase VII-deficient animals, which lack E/P-selectin ligands and fail to migrate into inflamed sites, we analyzed the functional importance of appropriate Treg localization for in vivo suppressive capacity in an inflammation model. Lack of suppression by Tregs deficient in E/P-selectin ligands demonstrates that immigration into inflamed sites is a prerequisite for the resolution of inflammatory reactions in vivo because these selectin ligands merely regulate entry into inflamed tissues. In contrast, control of proliferation of naive CD4+ T cells during the induction phase of the immune response is more efficiently exerted by the naive-like αE–CD25+ Treg subset preferentially recirculating through lymph nodes when compared with its inflammation-seeking counterpart. Together, these findings provide the first conclusive evidence that appropriate localization is crucial for in vivo activity of Tregs and might have significant implications for anti-inflammatory therapies targeting recruitment mechanisms.